Overview

Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the combination regimen of satraplatin and paclitaxel in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC).
Phase:
Phase 2
Details
Lead Sponsor:
Agennix
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel
Satraplatin